The immunology of ankylosing spondylitis and rheumatoid arthritis: a tale of similarities and dissimilarities
- PMID: 19822042
The immunology of ankylosing spondylitis and rheumatoid arthritis: a tale of similarities and dissimilarities
Abstract
Ankylosing spondylitis (AS) and rheumatoid arthritis (RA) are immune-mediated inflammatory joint diseases with the potential for significant target organ damage. Genetic factors play an important role in defining disease susceptibility. Both diseases are mediated in part by TNF, since anti-TNF therapies have proved effective in both AS and RA. Despite their similarities, the genetic elements associated with the respective diseases differ, most notably in HLA associations, with AS being associated with class I HLA alleles and RA associated with class II HLA alleles. AS has a predilection for axial joints whereas RA targets peripheral joints, but the immunological basis of that distinction is unknown. Autoantibody formation is the immunological hallmark of RA, whereas AS is notable for being a "seronegative" disease. Growing knowledge of new aspects of the host immune response (such as innate immune responses and Th17 cells) is adding to new insights into shared mechanisms of pathogenesis between these two diseases.
Similar articles
-
HLA haplotypes in a family with ankylosing spondylitis and rheumatoid arthritis.J Rheumatol. 1985 Jun;12(3):518-22. J Rheumatol. 1985. PMID: 3876435
-
A systematic survey of the HLA B27 prevalence in inflammatory rheumatic diseases.J Rheumatol. 1978 Winter;5(4):452-9. J Rheumatol. 1978. PMID: 739494
-
Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.Arthritis Rheum. 2004 Jul;50(7):2113-21. doi: 10.1002/art.20316. Arthritis Rheum. 2004. PMID: 15248208
-
Differences in pathophysiology between rheumatoid arthritis and ankylosing spondylitis.Clin Exp Rheumatol. 2009 Jul-Aug;27(4 Suppl 55):S10-4. Clin Exp Rheumatol. 2009. PMID: 19822039 Review.
-
Genetics of ankylosing spondylitis and rheumatoid arthritis: where are we at currently, and how do they compare?Clin Exp Rheumatol. 2009 Jul-Aug;27(4 Suppl 55):S20-5. Clin Exp Rheumatol. 2009. PMID: 19822041 Review.
Cited by
-
Insights into the pathogenesis of axial spondyloarthropathy from network and pathway analysis.BMC Syst Biol. 2012;6 Suppl 1(Suppl 1):S4. doi: 10.1186/1752-0509-6-S1-S4. Epub 2012 Jul 16. BMC Syst Biol. 2012. PMID: 23046677 Free PMC article.
-
Adaptive immunity in ankylosing spondylitis: phenotype and functional alterations of T-cells before and during infliximab therapy.Clin Dev Immunol. 2012;2012:808724. doi: 10.1155/2012/808724. Epub 2011 Sep 28. Clin Dev Immunol. 2012. PMID: 21969839 Free PMC article. Clinical Trial.
-
Periodontal condition is associated with disease duration and motoric disabilities in patients with ankylosing spondylitis: results of a cross-sectional study.Rheumatol Int. 2018 May;38(5):855-863. doi: 10.1007/s00296-018-4012-6. Epub 2018 Mar 20. Rheumatol Int. 2018. PMID: 29557489
-
Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritis.Clin Exp Rheumatol. 2011 Mar-Apr;29(2):322-30. Epub 2011 Apr 19. Clin Exp Rheumatol. 2011. PMID: 21269576 Free PMC article. Review.
-
T helper cell subsets in arthritis and the benefits of immunomodulation by 1,25(OH)₂ vitamin D.Rheumatol Int. 2012 Apr;32(4):845-52. doi: 10.1007/s00296-011-2077-6. Epub 2011 Sep 15. Rheumatol Int. 2012. PMID: 21918899 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials